Santiago A. H.
- Country
- Spain
- Department
- Ophthalmology
Research Overview
- Evaluation of Ranibizumab Port Delivery System Refill Regimens in Neovascular Age-Related Macular Degeneration: A Phase IIIb Randomized Study
- Evaluation of Elamipretide Subcutaneous Injections in Patients with Dry Age-Related Macular Degeneration: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Trial
- Evaluation of Long-Term Safety and Tolerability of Ranibizumab via Port Delivery System in Neovascular Age-Related Macular Degeneration Patients
Data & Insights
Has run more than one trial at 78 of 168 partner sites.
Specializations
Macular Degeneration Management
Specializes in treating various forms of age-related macular degeneration (AMD), with particular focus on both neovascular (wet) and dry variants of the condition. The investigator explores innovative delivery systems and therapeutic approaches for managing AMD.
- Port Delivery System Technology
- Ranibizumab Administration
- Long-term AMD Treatment Strategies
Advanced expertise in evaluating sustained-release drug delivery platforms for retinal conditions.
Geographic Atrophy Interventions
Focuses on developing treatments for geographic atrophy, investigating novel therapeutic compounds and genetic approaches. The investigator evaluates complement inhibition strategies and innovative biological interventions.
- Complement System Modulation
- Gene Therapy Applications
- Progressive Vision Loss Prevention
Expertise in monitoring geographic atrophy progression and therapeutic response assessment.
Retinal Disease Innovation
Conducts research in advanced treatments for diabetic macular edema and related retinal conditions. The investigator evaluates comparative efficacy of various therapeutic agents and delivery methods.
- Anti-VEGF Therapy
- Novel Therapeutic Compounds
- Visual Acuity Optimization
Specialized focus on developing improved treatment protocols for retinal disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
